Estimating the prevalence, clinical characteristics, and treatment patterns of hypertrophic cardiomyopathy in Japan: A nationwide medical claims database study-Reference-Cited by-同舟云学术

Estimating the prevalence, clinical characteristics, and treatment patterns of hypertrophic cardiomyopathy in Japan: A nationwide medical claims database study

Published:2023-03 Issue:3 Volume:81 Page:316-322
ISSN:0914-5087
Container-title:Journal of Cardiology
language:en
Short-container-title:Journal of Cardiology

Author:

Terasaka Naoki,Spanopoulos Dionysis,Miyagoshi Hidetaka,Kubo Toru,Kitaoka Hiroaki

Funder

Bristol-Myers Squibb

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference34 articles.

1. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;Gersh;Circulation,2011

2. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC);Elliott;Eur Heart J,2014

3. Hypertrophic cardiomyopathy: a heterogeneous and lifelong disease in real world;Kitaoka;Circ J,2020

4. JCS/JHFS 2018 Guideline on the diagnosis and treatment of cardiomyopathies;Kitaoka;Circ J,2021

5. Hospital volume outcomes after septal myectomy and alcohol septal ablation for treatment of obstructive hypertrophic cardiomyopathy: US nationwide inpatient database, 2003–2011;Kim;JAMA Cardiol,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An evidence review and gap analysis for obstructive hypertrophic cardiomyopathy;BMC Cardiovascular Disorders;2024-08-10

2. Hypertrophic Cardiomyopathy Predicts Thromboembolism and Heart Failure in Patients With Nonvalvular Atrial Fibrillation　― A Prospective Analysis From the Hokuriku-Plus AF Registry ―;Circulation Journal;2023-11-24